Medicare patients will have access to real-time prescription drug pricing and streamlined prior authorization decisions starting in October, HHS announced.
Pfizer and BioNTech will run a trial testing their COVID-19 vaccine’s safety and efficacy in healthy adults aged 50–64 without high-risk conditions.